Tahoe Therapeutics

About Tahoe Therapeutics

Tahoe (previously Vevo Therapeutics) is focused on mapping how chemistry perturbs biology to build virtual models of human cells. Their platform generates hundreds of millions of single-cell data points to understand drug-patient interactions, aiming to discover precision drugs for large cohorts, starting with cancer. They are committed to curing disease through open collaboration and innovative AI models.

Products & Services

Virtual Cell Models:Foundation models pre-trained to learn gene functions in diverse biological contexts, aimed at drug discovery.

Gigascale Single-Cell Maps:A new data modality generating massive perturbational single-cell data to train AI models for therapeutic discoveries.

TahoeDive:A platform or tool introduced for data interaction and exploration, featured at events like Databricks AI + Agents 2025.

Tahoe-100M:The world's largest open-sourced single-cell dataset, contributing to virtual cell atlas initiatives.

Specialties

Virtual Cell Modeling Single-Cell Data Analysis AI for Drug Discovery Cancer Therapeutics Perturbational Data Mapping

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Venture Round T: - FT: Venture Round	A: 30000000 MR: - FA: $30 million FAN: 30000000	D: 2025-08-11 FD: 2025-08-11	8 investors

Venture Round Latest

2025-08-11

$30.0M

8 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

N

Nima Alidoust

CEO & Cofounder

LinkedIn (Pro only)

J

Johnny Yu

CSO & Cofounder

LinkedIn (Pro only)

H

Hani Goodarzi

Cofounder

LinkedIn (Pro only)

K

Kevan Shokat

Cofounder

S

Shreshth Gandhi

CompBio - Machine Learning

H

Harper Green

Biology - Research

View 11 more team members with Pro

Unlock Full Team Directory

Recent News